Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intratumor genetic heterogeneity in squamous cell carcinoma of the oral cavity.
Zandberg DP, Tallon LJ, Nagaraj S, Sadzewicz LK, Zhang Y, Strome MB, Zhao XE, Vavikolanu K, Zhang X, Papadimitriou JC, Hubbard FA, Bentzen SM, Strome SE, Fraser CM. Zandberg DP, et al. Among authors: hubbard fa. Head Neck. 2019 Aug;41(8):2514-2524. doi: 10.1002/hed.25719. Epub 2019 Mar 14. Head Neck. 2019. PMID: 30869813 Free article.
Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks.
Palechor-Ceron N, Krawczyk E, Dakic A, Simic V, Yuan H, Blancato J, Wang W, Hubbard F, Zheng YL, Dan H, Strome S, Cullen K, Davidson B, Deeken JF, Choudhury S, Ahn PH, Agarwal S, Zhou X, Schlegel R, Furth PA, Pan CX, Liu X. Palechor-Ceron N, et al. Among authors: hubbard f. Cells. 2019 Oct 27;8(11):1327. doi: 10.3390/cells8111327. Cells. 2019. PMID: 31717887 Free PMC article. Review.
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial.
Kalil AC, Mehta AK, Patterson TF, Erdmann N, Gomez CA, Jain MK, Wolfe CR, Ruiz-Palacios GM, Kline S, Regalado Pineda J, Luetkemeyer AF, Harkins MS, Jackson PEH, Iovine NM, Tapson VF, Oh MD, Whitaker JA, Mularski RA, Paules CI, Ince D, Takasaki J, Sweeney DA, Sandkovsky U, Wyles DL, Hohmann E, Grimes KA, Grossberg R, Laguio-Vila M, Lambert AA, Lopez de Castilla D, Kim E, Larson L, Wan CR, Traenkner JJ, Ponce PO, Patterson JE, Goepfert PA, Sofarelli TA, Mocherla S, Ko ER, Ponce de Leon A, Doernberg SB, Atmar RL, Maves RC, Dangond F, Ferreira J, Green M, Makowski M, Bonnett T, Beresnev T, Ghazaryan V, Dempsey W, Nayak SU, Dodd L, Tomashek KM, Beigel JH; ACTT-3 study group members. Kalil AC, et al. Lancet Respir Med. 2021 Dec;9(12):1365-1376. doi: 10.1016/S2213-2600(21)00384-2. Epub 2021 Oct 18. Lancet Respir Med. 2021. PMID: 34672949 Free PMC article. Clinical Trial.
2020 design and methods of the Population Assessment of Tobacco and Health (PATH) study during the COVID-19 pandemic.
DiGaetano R, Dohrmann S, Taylor EV, Everard CD, Castleman V, Yan T, Kimmel HL, Zandberg I, Piesse A, Opsomer JD, Borek N, Silveira ML, Hubbard F, Taylor K, Creamer MR, Salim AH, Sharma E, Cheng YC, Vignare V, Cook T, Szeszel-Fedorowicz W, Siegfried Y, Carusi C, Stark D, Skara S, Hyland A. DiGaetano R, et al. Among authors: hubbard f. Tob Control. 2024 Apr 26:tc-2023-058466. doi: 10.1136/tc-2023-058466. Online ahead of print. Tob Control. 2024. PMID: 38670795 Free article.
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
Efficacy of typhoid conjugate vaccine: final analysis of a 4-year, phase 3, randomised controlled trial in Malawian children.
Patel PD, Liang Y, Meiring JE, Chasweka N, Patel P, Misiri T, Mwakiseghile F, Wachepa R, Banda HC, Shumba F, Kawalazira G, Dube Q, Nampota-Nkomba N, Nyirenda OM, Girmay T, Datta S, Jamka LP, Tracy JK, Laurens MB, Heyderman RS, Neuzil KM, Gordon MA; TyVAC team. Patel PD, et al. Lancet. 2024 Feb 3;403(10425):459-468. doi: 10.1016/S0140-6736(23)02031-7. Epub 2024 Jan 25. Lancet. 2024. PMID: 38281499 Free PMC article. Clinical Trial.
Update to the design and methods of the PATH Study, Wave 4 (2016-2017).
Opsomer JD, Dohrmann S, DiGaetano R, Piesse A, Taylor E, Creamer MR, Han D, Everard C, Borek N, Hubbard F, Zandberg I, Kanel M, Taylor K, Kimmel HL, Paredes A, Siegfried Y, Cheng YC, Kwan J, Carusi C, Hyland A. Opsomer JD, et al. Among authors: hubbard f. Tob Control. 2024 Oct 19;33(6):733-738. doi: 10.1136/tc-2022-057851. Tob Control. 2024. PMID: 37258274 Free PMC article.
50 results